These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 10808079

  • 1. Blocking the trigeminal EPSP in rat abducens motoneurons in vivo with the AMPA antagonists NBQX and GYKI 53655.
    Ruiz A, Durand J.
    Brain Res Bull; 2000 May 15; 52(2):99-107. PubMed ID: 10808079
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Comparative patch clamp studies on the kinetics and selectivity of glutamate receptor antagonism by 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline (NBQX) and 1-(4-amino-phenyl)-4-methyl-7,8-methyl-endioxyl-5H-2,3-benzodiaze pine (GYKI 52466).
    Parsons CG, Gruner R, Rozental J.
    Neuropharmacology; 1994 May 15; 33(5):589-604. PubMed ID: 7523977
    [Abstract] [Full Text] [Related]

  • 4. Involvement of AMPA receptors in trigeminal post-synaptic potentials recorded in rat abducens motoneurons in vivo.
    Ouardouz M, Durand J.
    Eur J Neurosci; 1994 Nov 01; 6(11):1662-8. PubMed ID: 7874305
    [Abstract] [Full Text] [Related]

  • 5. GYKI 52466 antagonizes glutamate responses but not NMDA and kainate responses in rat abducens motoneurones.
    Ouardouz M, Durand J.
    Neurosci Lett; 1991 Apr 15; 125(1):5-8. PubMed ID: 1830380
    [Abstract] [Full Text] [Related]

  • 6. A comparison of intravenous NBQX and GYKI 53655 as AMPA antagonists in the rat spinal cord.
    Chizh BA, Cumberbatch MJ, Headley PM.
    Br J Pharmacol; 1994 Jul 15; 112(3):843-6. PubMed ID: 7522860
    [Abstract] [Full Text] [Related]

  • 7. Local mechanisms of phase-dependent postsynaptic modifications of NMDA-induced oscillations in the abducens motoneurons: a simulation study.
    Kopysova IL, Korogod SM, Durand J, Tyc-Dumont S.
    J Neurophysiol; 1996 Aug 15; 76(2):1015-24. PubMed ID: 8871216
    [Abstract] [Full Text] [Related]

  • 8. AMPA receptor antagonists, GYKI 52466 and NBQX, do not block the induction of long-term potentiation at therapeutically relevant concentrations.
    Kapus G, Székely JI, Durand J, Ruiz A, Tarnawa I.
    Brain Res Bull; 2000 Aug 15; 52(6):511-7. PubMed ID: 10974490
    [Abstract] [Full Text] [Related]

  • 9. Allosteric interactions between cyclothiazide and AMPA/kainate receptor antagonists.
    Yamada KA, Turetsky DM.
    Br J Pharmacol; 1996 Apr 15; 117(8):1663-72. PubMed ID: 8732274
    [Abstract] [Full Text] [Related]

  • 10. Participation of NMDA and non-NMDA excitatory amino acid receptors in the mediation of spinal reflex potentials in rats: an in vivo study.
    Farkas S, Ono H.
    Br J Pharmacol; 1995 Mar 15; 114(6):1193-205. PubMed ID: 7620709
    [Abstract] [Full Text] [Related]

  • 11. Differential roles for NMDA and non-NMDA receptor subtypes in baroreceptor afferent integration in the nucleus of the solitary tract of the rat.
    Zhang J, Mifflin SW.
    J Physiol; 1998 Sep 15; 511 ( Pt 3)(Pt 3):733-45. PubMed ID: 9714856
    [Abstract] [Full Text] [Related]

  • 12. Synaptic excitation triggers oscillations during NMDA receptor activation in rat abducens motoneurons.
    Durand J.
    Eur J Neurosci; 1993 Oct 01; 5(10):1389-97. PubMed ID: 7903893
    [Abstract] [Full Text] [Related]

  • 13. Excitatory amino acids and synaptic transmission in embryonic rat brainstem motoneurons in organotypic culture.
    Launey T, Ivanov A, Kapus G, Ferrand N, Tarnawa I, Gueritaud JP.
    Eur J Neurosci; 1999 Apr 01; 11(4):1324-34. PubMed ID: 10103128
    [Abstract] [Full Text] [Related]

  • 14. Effects of the non-NMDA antagonists NBQX and the 2,3-benzodiazepine GYKI 52466 on different seizure types in mice: comparison with diazepam and interactions with flumazenil.
    Löscher W, Hönack D.
    Br J Pharmacol; 1994 Dec 01; 113(4):1349-57. PubMed ID: 7889291
    [Abstract] [Full Text] [Related]

  • 15. Late embryonic expression of AMPA receptor function in the CA1 region of the intact hippocampus in vitro.
    Diabira D, Hennou S, Chevassus-Au-Louis N, Ben-Ari Y, Gozlan H.
    Eur J Neurosci; 1999 Nov 01; 11(11):4015-23. PubMed ID: 10583490
    [Abstract] [Full Text] [Related]

  • 16. GYKI 53665, a 2,3-benzodiazepine, non-competitively protects cultured neurones against AMPA toxicity.
    Kovács AD, Szabó G.
    Eur J Pharmacol; 1997 Jul 16; 331(1):93-6. PubMed ID: 9274935
    [Abstract] [Full Text] [Related]

  • 17. Cyclothiazide reverses AMPA receptor antagonism of the 2,3-benzodiazepine, GYKI 53655.
    Palmer AJ, Lodge D.
    Eur J Pharmacol; 1993 Jan 15; 244(2):193-4. PubMed ID: 7679352
    [Abstract] [Full Text] [Related]

  • 18. AMPA receptors have an equal role in spinal nociceptive and non-nociceptive transmission.
    Cumberbatch MJ, Chizh BA, Headley PM.
    Neuroreport; 1994 Apr 14; 5(8):877-80. PubMed ID: 7520299
    [Abstract] [Full Text] [Related]

  • 19. Competitive inhibition by NBQX of kainate/AMPA receptor currents and excitatory synaptic potentials: importance of 6-nitro substitution.
    Randle JC, Guet T, Cordi A, Lepagnol JM.
    Eur J Pharmacol; 1992 May 14; 215(2-3):237-44. PubMed ID: 1382998
    [Abstract] [Full Text] [Related]

  • 20. Characterization of YM90K, a selective and potent antagonist of AMPA receptors, in rat cortical mRNA-injected Xenopus oocytes.
    Okada M, Kohara A, Yamaguchi T.
    Eur J Pharmacol; 1996 Aug 15; 309(3):299-306. PubMed ID: 8874154
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.